Testing weight-loss surgery follow-up and gastric “recalibration”
Part of Hormones & metabolism clinical trials.
This trial studies what happens after a weight-loss procedure called endoscopic sleeve gastroplasty (ESG) and whether a “recalibration” approach can improve results. You may be considered if you have long-term obesity that did not improve with lifestyle/medical treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 75
- Have obesity (BMI 30+ with health problems, or BMI over 40) and it has lasted over 2 years
- Have tried medical treatment for weight loss and it did not work
- Be able to safely have general anesthesia (sleep medicine for surgery) and join follow-up visits reliably
- Be able to understand the study and give informed consent; have French social security coverage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called Endoscopic Sleeve Gastroplasty (ESG) as a non-surgical option for weight loss. It aims to help people who have not been able to lose weight with diet and exercise, and who either cannot or prefer not to have bariatric surgery.
This study tests a new procedure called endoscopic sleeve gastroplasty with fundal mucosal ablation to help with weight loss. It is an option for people with obesity who have not had success with other methods and who have not had prior stomach surgery.
This study tracks people with obesity who get an endoscopic sleeve gastrectomy, a procedure that reduces stomach size without surgery. The goal is to see how safe and effective it is in everyday practice.
This study tests a stomach procedure (endoscopy) to help people with obesity lose weight or control health problems linked to weight. You may be considered if other weight-loss efforts have not worked and surgery is not the best option for you.
This study looks at how a procedure called endoscopic sleeve gastroplasty (a way to reduce stomach size without surgery) affects hormones and gut bacteria. It may help people with obesity lose weight and improve related health issues.
This trial tests a combined procedure that uses stomach stapling (endoscopic sleeve gastroplasty) plus ablation of the stomach lining to help with weight loss. It is for people with obesity who have not been able to lose weight with diet, exercise, or medication alone.
Hear when a new Morbid Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.